Notable
RADIANCE-II · RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
Primary endpoint(s) modified
Also in this update: Results posted: Sep 24, 2026; Study completion pushed from Jul 2027 to Jul 2029
ReCor Medical, Inc.Not applicable NCT03614260 Registry history of NCT03614260 on ClinicalTrials.gov (opens the registry)
Updated